Clonal immunoglobulin against lysolipids in the origin of myeloma

New England Journal of Medicine

Volumn 374, Issue 6, 2016, Pages 555-561

  Nair, Shiny ^a   Branagan, Andrew R ^a   Liu, Jun ^a   Boddupalli, Chandra Sekhar ^a   Mistry, Pramod K ^a   Dhodapkar, Madhav V ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN; GLUCOSYLCERAMIDE; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; LIPID A; LYSO GLUCOSYLCERAMIDE; LYSOPHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG; IMMUNOGLOBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE ACTIVATION; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; GAUCHER DISEASE; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; IN VIVO STUDY; MONOCLONAL IMMUNOGLOBULINEMIA; MOUSE; MULTIPLE MYELOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; ANIMAL; COMPLICATION; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; PARAPROTEINEMIA;

ANIMALS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GAUCHER DISEASE; GLUCOSYLCERAMIDES; HUMANS; IMMUNOGLOBULINS; LYSOPHOSPHATIDYLCHOLINES; MICE; MULTIPLE MYELOMA; PARAPROTEINEMIAS;

EID: 84959307535     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1508808     Document Type: Article

References (25)

1. Palumbo A, Anderson K. Multiple myeloma. N Engl J Med 2011; 364: 1046-60.
2. Sahota SS, Leo R, Hamblin TJ, Stevenson FK. Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells. Blood 1997; 89: 219-26.
3. Sahota SS, Leo R, Hamblin TJ, Stevenson FK. Ig VH gene mutational patterns indicate different tumor cell status in human myeloma and monoclonal gammopathy of undetermined significance. Blood 1996; 87: 746-55.
4. Zojer N, Ludwig H, Fiegl M, Stevenson FK, Sahota SS. Patterns of somatic mutations in VH genes reveal pathways of clonal transformation from MGUS to multiple myeloma. Blood 2003; 101: 4137-9.
5. Bakkus MH, Heirman C, Van Riet I, Van Camp B, Thielemans K. Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood 1992; 80: 2326-35.
6. Vescio RA, Cao J, Hong CH, et al. Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity. J Immunol 1995; 155: 2487-97.
7. Preuss KD, Pfreundschuh M, Ahlgrimm M, et al. A frequent target of paraproteins in the sera of patients with multiple myeloma and MGUS. Int J Cancer 2009; 125: 656-61.
8. Grass S, Preuss KD, Thome S, et al. Paraproteins of familial MGUS/multiple myeloma target family-typical antigens: hyperphosphorylation of autoantigens is a consistent finding in familial and sporadic MGUS/MM. Blood 2011; 118: 635-7.
9. Preuss KD, Pfreundschuh M, Fadle N, et al. Hyperphosphorylation of autoantigenic targets of paraproteins is due to inactivation of PP2A. Blood 2011; 118: 3340-6.
10. Preuss KD, Pfreundschuh M, Weigert M, Fadle N, Regitz E, Kubuschok B. Sumoylated HSP90 is a dominantly inherited plasma cell dyscrasias risk factor. J Clin Invest 2015; 125: 316-23.
11. Anderson PN, Potter M. Induction of plasma cell tumours in BALB-c mice with 2,6,10,14-tetramethylpentadecane (pristane). Nature 1969; 222: 994-5.
12. Landgren O, Rajkumar SV, Pfeiffer RM, et al. Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women. Blood 2010; 116: 1056-9.
13. Mistry PK, Taddei T, vom Dahl S, Rosenbloom BE. Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism. Crit Rev Oncog 2013; 18: 235-46.
14. Dekker N, van Dussen L, Hollak CE, et al. Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response. Blood 2011; 118(16): e118-27.
15. Nair S, Boddupalli CS, Verma R, et al. Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation. Blood 2015; 125: 1256-71.
16. Chang DH, Deng H, Matthews P, et al. Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer. Blood 2008; 112: 1308-16.
17. Mistry PK, Liu J, Yang M, et al. Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage. Proc Natl Acad Sci USA 2010; 107: 19473-8.
18. Nooij FJ, Van der Sluijs-Gelling AJ, Jol-Van der Zijde CM, Van Tol MJ, Haas H, Radl J. Immunoblotting techniques for the detection of low level homogeneous immunoglobulin components in serum. J Immunol Methods 1990; 134: 273-81.
19. Braun W, Abraham R. Modified diffusion blotting for rapid and efficient protein transfer with PhastSystem. Electrophoresis 1989; 10: 249-53.
20. Sasagawa T, Okita M, Murakami J, Kato T, Watanabe A. Abnormal serum lysophospholipids in multiple myeloma patients. Lipids 1999; 34: 17-21.
21. Koduru S, Wong E, Strowig T, et al. Dendritic cell-mediated activation-induced cytidine deaminase (AID)-dependent induction of genomic instability in human myeloma. Blood 2012; 119: 2302-9.
22. Mistry PK, Lukina E, Ben Turkia H, et al. Effect of oral eliglustat on splenomegaly in patients with Gaucher disease type 1: the ENGAGE randomized clinical trial. JAMA 2015; 313: 695-706.
23. Pavlova EV, Archer J, Wang S, et al. Inhibition of UDP-glucosylceramide synthase in mice prevents Gaucher diseaseassociated B-cell malignancy. J Pathol 2015; 235: 113-24.
24. Pietiläinen KH, Sysi-Aho M, Rissanen A, et al. Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects-a monozygotic twin study. PLoS One 2007; 2(2): e218.
25. Lwin ST, Olechnowicz SW, Fowler JA, Edwards CM. Diet-induced obesity promotes a myeloma-like condition in vivo. Leukemia 2015; 29: 507-10.